BidSonarBidSonar
ContractsGrantsOrganisationsSectors
BidSonarBidSonar·Built by Hypership
SourcesPrivacyTermsCookies

BidSonar is an independent index of public-sector opportunities. We aggregate data from official sources and are not affiliated with any procurement body. Data is licensed under the Open Government Licence v3.0 and the EU TED reuse notice.

    Contracts

    UK & EU public-sector contracts

    Every live tender notice from Contracts Finder, Find a Tender and TED — refreshed hourly, every record linking back to source.

    Live now
    4K
    Value in flight
    £337.9bn
    Countries covered
    56
    On record
    74K

    Contract index

    OpenHealthcare & Medical🇩🇪Germany

    Non-Exclusive Discount Agreement for Adapalene and Benzoyl Peroxide

    This contract involves a non-exclusive discount agreement for the pharmaceutical substances Adapalene and Benzoyl Peroxide, classified under ATC code D10AD23. The agreement is established under Section 130a, Paragraph 8 of the German Social Code (SGB V), allowing health insurance funds and pharmaceu

    €1DAK HEALTH
    Published 14 Dec 2025Closes in 30 months
    Previous1...176177178...183Next
    Open
    Healthcare & Medical
    🇩🇪Germany

    Open House Discount Contracts for Alfacalcidol in Germany

    This is not a standard open procedure but an open-house model! The form for the open procedure is used only because there is no form for the open-house model. Contracts made under the open-house model are not subject to procurement law due to the lack of a selection decision. The AOK Bayern intends

    AOK BAYERN THE HEALTH INSURANCE FUND
    Published 14 Dec 2025Closes in 18 months
    OpenHealthcare & Medical🇩🇪Germany

    Open House Discount Contracts for Olmesartan and Hydrochlorothiazide

    This contract opportunity involves the establishment of non-exclusive discount contracts for the medications Olmesartan and Hydrochlorothiazide. These contracts will be in effect from February 1, 2026, to January 31, 2028, and can be signed at any time during this period (open-house model). Please n

    AOK RHEINLANDPFALZSAARLAND THE HEALTH FUND
    Published 9 Dec 2025Closes in 18 months
    OpenHealthcare & Medical🇩🇪Germany

    Open House Discount Contracts for Alfacalcidol

    This contract opportunity involves the establishment of non-exclusive discount contracts for the pharmaceutical Alfacalcidol, in accordance with specific regulations, for the period from February 1, 2026, to January 31, 2028. Suppliers can enter into contracts at any time during this period, followi

    AOK RHEINLANDPFALZSAARLAND THE HEALTH FUND
    Published 9 Dec 2025Closes in 18 months
    OpenHealthcare & Medical🇩🇪Germany

    Open House Discount Contracts for Naproxen and Esomeprazole

    This contract opportunity involves the establishment of non-exclusive discount contracts for the pharmaceutical products Naproxen and Esomeprazole, in accordance with German social law. The contracts will be valid from February 1, 2026, to January 31, 2028, and suppliers can enter into contracts at

    AOK RHEINLANDPFALZSAARLAND THE HEALTH FUND
    Published 9 Dec 2025Closes in 18 months
    OpenHealthcare & Medical🇩🇪Germany

    Open House Discount Contracts for Glatiramer Acetate

    This contract opportunity involves the establishment of non-exclusive discount contracts for the medication Glatiramer Acetate, specifically for pre-filled syringes. The contracts will be in effect from February 1, 2026, to January 31, 2028, with the option for suppliers to enter into contracts at a

    AOK RHEINLANDPFALZSAARLAND THE HEALTH FUND
    Published 9 Dec 2025Closes in 18 months
    OpenHealthcare & Medical🇩🇪Germany

    Germany – Timolol Medication Contracts

    This contract opportunity involves the establishment of non-exclusive discount agreements for finished medications containing the active ingredient Timolol (ATC: S01ED01) under an 'open-house model'. All eligible and interested pharmaceutical companies or consortia are invited to enter into or join

    AOK SACHSEN ANHALT
    Published 7 Dec 2025Closes in 18 months
    OpenHealthcare & Medical🇩🇪Germany

    Open-House Discount Contracts for Epoetin Beta in Germany (2025-39)

    This contract opportunity is for pharmaceutical companies to enter into discount agreements for the drug Epoetin beta, as part of the Open-House-Biologika process. The participating health insurance funds aim to establish uniform discount contracts without individual negotiations, ensuring no exclus

    TECHNIKER HEALTH INSURANCE
    Published 3 Dec 2025Closes in 20 months
    OpenMedia & Communications🇮🇪Ireland

    Panel for Past Exam Papers and Online Study Support

    The Waterford and Wexford Education and Training Board is seeking suppliers to provide past exam papers and online study support for Post Primary Schools and Youthreach centres. This opportunity is divided into three categories: 1) Hard copy English version of past exam papers, 2) Hard copy Irish ve

    €210,000WATERFORD AND WEXFORD EDUCATION AND TRAINING BOARD110494
    Published 3 Dec 2025Closes in 18 months
    OpenHealthcare & Medical🇩🇪Germany

    Germany – Pharmaceutical Discounts Agreement

    The Kaufmännische Krankenkasse (KKH) aims to establish discount agreements with all suitable pharmaceutical companies for the specified active ingredients under the Open-House procedure as per § 130a paragraph 8 of the Social Code Book V. This process will provide uniform contract conditions and acc

    KKH COMMERCIAL HEALTH INSURANCE
    Published 30 Nov 2025Closes in 28 weeks
    OpenConstruction🇩🇪Germany

    Installation of Electrical Wiring at Alanbrooke Business Center in Paderborn

    This project involves the renovation of a former barracks building (Block 4) located at Alan-Brooke-Weg 4, 33102 Paderborn. The building has a basement, ground floor, first floor, second floor, and an attic. The ceiling heights reach up to approximately 3.70 meters from the raw ceiling. The finished

    ALANBROOKE BLOCK 4 UG LIMITED LIABILITY
    Published 25 Nov 2025Closes in 25 weeks
    OpenHealthcare & Medical🇩🇪Germany

    Germany – Pharmaceutical Agreements

    This contract opportunity involves establishing non-exclusive discount agreements for various active substances and combinations under Section 130a (8) of the Social Code Book V (SGB V) through an Open House procedure. Suppliers are invited to submit proposals for the supply of pharmaceuticals, whic

    AOK NORDOST THE HEALTH FUND
    Published 23 Nov 2025Closes in 17 months
    OpenHealthcare & Medical🇩🇪Germany

    Framework Agreement for Pharmaceuticals with Option to Join

    This announcement is not related to the awarding of a public contract as defined by the Public Procurement Directive (2014/24/EU) or competition law. To ensure broad information dissemination to interested pharmaceutical companies, this announcement is published in the Supplement to the Official Jou

    BARMER PROCUREMENT AND AWARD
    Published 20 Nov 2025Closes in 17 months
    OpenHealthcare & Medical🇩🇪Germany

    Open-House Discount Contracts for Pharmaceuticals in Germany (2024-11)

    The health insurance funds (whether HEK and/or hkk participate in each lot is determined by the designation of the respective lot) aim to enter into discount contracts with all suitable pharmaceutical companies according to § 130a Abs. 8 SGB V for the active ingredients, combinations of active ingre

    TECHNIKER HEALTH INSURANCE
    Published 18 Nov 2025Closes in 20 weeks
    OpenHealthcare & Medical🇩🇪Germany

    Open-House Discount Contracts for Pharmaceuticals in Germany 2024-08

    The health insurance funds (whether HEK and/or hkk participate in each lot is determined by the designation of the respective lot) aim to establish discount contracts with all suitable pharmaceutical companies according to § 130a Abs. 8 SGB V for the active ingredients, combinations of active ingred

    TECHNIKER HEALTH INSURANCE
    Published 18 Nov 2025Closes in 7 weeks
    OpenHealthcare & Medical🇩🇪Germany

    Germany – Medicines – Medicines with the Active Ingredient Abaloparatide (ATC: H05AA04)

    This publication is about entering into non-exclusive discount contracts according to § 130a Abs. 8 SGB V for finished medicines containing the active ingredient Abaloparatide (ATC: H05AA04) as part of an "open-house model". Under uniform contract conditions and a standardized access procedure, all

    AOK SACHSEN ANHALT
    Published 18 Nov 2025Closes in 17 months
    OpenHealthcare & Medical🇩🇪Germany

    Pharmaceutical Discount Contracts in Germany Starting January 1, 2026

    This contract opportunity involves the establishment of discount contracts for various active ingredients under the Open-House procedure, as per § 130a Abs. 8 SGB V. All eligible and interested pharmaceutical companies or consortia are invited to enter into discount contracts under uniform terms and

    AOK NORDWEST
    Published 10 Nov 2025Closes in 17 months
    OpenHealthcare & Medical🇫🇷France

    Medical Devices for Mechanical Thrombectomy

    This contract opportunity is for the procurement of endovascular devices specifically designed for mechanical thrombectomy procedures. The buyer, CH GPE HOSP DE LA ROCHELLE RE AUNIS, is seeking suppliers to provide two lots of these medical devices. The aim is to enhance healthcare services in the r

    CH GPE HOSP DE LA ROCHELLE RE AUNIS
    Published 6 Nov 2025Closes in 26 weeks
    OpenHealthcare & Medical🇩🇪Germany

    Germany – Pharmaceutical Discounts Agreement

    The KKH (Kaufmännische Krankenkasse) aims to establish discount agreements with all suitable pharmaceutical companies for the specified active ingredients under the Open-House procedure as per § 130a Abs. 8 SGB V. This process allows all eligible and interested pharmaceutical companies or groups to

    KKH COMMERCIAL HEALTH INSURANCE
    Published 5 Nov 2025Closes in 28 weeks
    OpenHealthcare & Medical🇩🇪Germany

    Germany – Pharmaceutical Discounts – Non-Exclusive Discount Agreements for Active Ingredients

    The Kaufmännische Krankenkasse (KKH) aims to establish non-exclusive discount agreements with all suitable pharmaceutical companies for the active ingredients specified in this contract, following the Open-House procedure. This process allows all eligible and interested pharmaceutical companies or c

    KKH COMMERCIAL HEALTH INSURANCE
    Published 4 Nov 2025Closes in 28 weeks